Department of Physiology, School of Medicine, Koç University, Istanbul, Turkey; Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.
School of Medicine, Koç University, Istanbul, Turkey.
Microvasc Res. 2021 May;135:104124. doi: 10.1016/j.mvr.2020.104124. Epub 2021 Jan 14.
Red blood cell (RBC) deformability has vital importance for microcirculation in the body, as RBCs travel in narrow capillaries under shear stress. Deformability can be defined as a remarkable cell ability to change shape in response to an external force which allows the cell to pass through the narrowest blood capillaries. Previous studies showed that RBC deformability could be regulated by Ca/protein kinase C (PKC) signaling mechanisms due to the phosphorylative changes in RBC membrane proteins by kinases and phosphatases. We investigated the roles of Ca/PKC signaling pathway on RBC mechanical responses and impaired RBC deformability under continuous shear stress (SS). A protein kinase C inhibitor Chelerythrine, a tyrosine phosphatase inhibitor Calpeptin, and a calcium channel blocker Verapamil were applied into human blood samples in 1 micromolar concentration. Samples with drugs were treated with or without 3 mM Ca. A shear stress at 5 Pa level was applied to each sample continuously for 300 s. RBC deformability was measured by a laser-assisted optical rotational cell analyzer (LORRCA) and was calculated as the change in elongation index (EI) of RBC upon a range of shear stress (SS, 0.3-50 Pa). RBC mechanical stress responses were evaluated before and after continuous SS through the parameterization of EI-SS curves. The drug administrations did not produce any significant alterations in RBC mechanical responses when they were applied alone. However, the application of the drugs together with Ca substantially increased RBC deformability compared to calcium alone. Verapamil significantly improved Ca-induced impairments of deformability both before and after 5 Pa SS exposure (p < 0.0001). Calpeptin and Chelerythrine significantly ameliorated impaired deformability only after continuous SS (p < 0.05). Shear-induced improvements of deformability were conserved by the drug administrations although shear-induced deformability was impaired when the drugs were applied with calcium. The blocking of Ca channel by Verapamil improved impaired RBC mechanical responses independent of the SS effect. The inhibition of tyrosine phosphatase and protein kinase C by Calpeptin and Chelerythrine, respectively, exhibited ameliorating effects on calcium-impaired deformability with the contribution of shear stress. The modulation of Ca/PKC signaling pathway could regulate the mechanical stress responses of RBCs when cells are under continuous SS exposure. Shear-induced improvements in the mechanical properties of RBCs by this signaling mechanism could facilitate RBC flow in the microcirculation of pathophysiological disorders, wherein Ca homeostasis is disturbed and RBC deformability is reduced.
红细胞(RBC)的变形能力对于体内微循环至关重要,因为 RBC 在切应力下流经狭窄的毛细血管。变形能力可以定义为细胞在外力作用下显著改变形状的能力,从而使细胞能够通过最窄的毛细血管。先前的研究表明,由于激酶和磷酸酶对 RBC 膜蛋白的磷酸化改变,RBC 变形能力可以通过 Ca/蛋白激酶 C(PKC)信号机制进行调节。我们研究了 Ca/ PKC 信号通路在 RBC 机械反应和持续切应力(SS)下 RBC 变形能力受损中的作用。在 1 微摩尔浓度下,将蛋白激酶 C 抑制剂 Chelerythrine、酪蛋白磷酸酶抑制剂 Calpeptin 和钙通道阻滞剂维拉帕米应用于人血样中。用或不用 3 mM Ca 处理含药物的样品。将 5 Pa 水平的切应力连续施加到每个样品 300 s。通过激光辅助光学旋转细胞分析仪(LORRCA)测量 RBC 变形能力,并计算 RBC 在一定范围内的切应力(SS,0.3-50 Pa)下伸长指数(EI)的变化。通过 EI-SS 曲线参数化,在连续 SS 前后评估 RBC 机械应激反应。当单独应用时,药物给药不会对 RBC 机械反应产生任何显著改变。然而,与单独使用钙相比,钙与药物联合应用会显著增加 RBC 变形能力。维拉帕米显著改善了 5 Pa SS 暴露前后 Ca 诱导的变形能力损伤(p<0.0001)。Calpeptin 和 Chelerythrine 仅在连续 SS 后显著改善了变形能力损伤(p<0.05)。尽管在应用钙时,切应力诱导的变形能力受损,但药物给药仍能保留变形能力的改善。维拉帕米通过阻断钙通道,独立于 SS 效应改善受损的 RBC 机械反应。Calpeptin 和 Chelerythrine 通过抑制酪蛋白磷酸酶和蛋白激酶 C,分别在 Ca 损伤变形能力方面表现出改善作用,这得益于切应力的作用。Ca/ PKC 信号通路的调节可以调节细胞在持续 SS 暴露下的 RBC 机械应激反应。通过这种信号机制,RBC 机械性能的切应力诱导改善可以促进病理生理紊乱微循环中 RBC 的流动,其中 Ca 稳态受到干扰,RBC 变形能力降低。